Abbott Laboratories ROE 2006-2018 | ABT

Current and historical return on equity (ROE) values for Abbott Laboratories (ABT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Abbott Laboratories ROE for the three months ending December 31, 2018 was 16.55%.
Abbott Laboratories ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-12-31 $2.37B $30.72B 7.64%
2018-09-30 $0.89B $30.90B 2.85%
2018-06-30 $0.93B $30.77B 2.95%
2018-03-31 $0.48B $31.60B 1.50%
2017-12-31 $0.48B $31.10B 1.51%
2017-09-30 $2.10B $32.22B 7.23%
2017-06-30 $1.17B $31.79B 4.46%
2017-03-31 $1.50B $31.55B 6.40%
2016-12-31 $1.40B $20.72B 6.73%
2016-09-30 $1.37B $20.90B 6.53%
2016-06-30 $2.28B $20.80B 10.82%
2016-03-31 $2.45B $20.84B 11.31%
2015-12-31 $4.42B $21.33B 20.18%
2015-09-30 $4.56B $21.22B 20.74%
2015-06-30 $4.52B $23.13B 20.14%
2015-03-31 $4.20B $21.99B 18.60%
2014-12-31 $2.28B $21.64B 9.95%
2014-09-30 $1.97B $22.99B 8.25%
2014-06-30 $2.40B $23.70B 9.96%
2014-03-31 $2.41B $23.49B 10.14%
2013-12-31 $2.58B $25.27B 10.94%
2013-09-30 $3.04B $23.79B 12.70%
2013-06-30 $4.02B $22.43B 16.22%
2013-03-31 $5.27B $22.68B 20.82%
2012-12-31 $5.96B $26.81B 22.93%
2012-09-30 $6.53B $27.10B 25.67%
2012-06-30 $4.89B $24.57B 19.69%
2012-03-31 $5.11B $25.54B 20.18%
2011-12-31 $4.73B $24.53B 18.84%
2011-09-30 $4.55B $24.69B 18.45%
2011-06-30 $5.14B $26.47B 21.54%
2011-03-31 $4.49B $24.72B 20.18%
2010-12-31 $4.63B $22.77B 21.71%
2010-09-30 $4.73B $21.48B 22.06%
2010-06-30 $5.31B $20.00B 24.84%
2010-03-31 $5.31B $21.01B 24.84%
2009-12-31 $5.75B $23.19B 27.87%
2009-09-30 $5.74B $21.38B 29.91%
2009-06-30 $5.35B $19.92B 28.61%
2009-03-31 $5.38B $17.98B 29.17%
2008-12-31 $4.88B $17.52B 26.45%
2008-09-30 $4.55B $19.35B 24.55%
2008-06-30 $4.18B $18.96B 23.76%
2008-03-31 $3.85B $17.98B 23.05%
2007-12-31 $3.61B $17.82B 22.87%
2007-09-30 $1.93B $15.61B 13.00%
2007-06-30 $1.93B $15.33B 12.99%
2007-03-31 $1.55B $14.32B 10.47%
2006-12-31 $1.72B $14.05B 11.58%
2006-09-30 $3.17B $15.63B 21.24%
2006-06-30 $3.13B $15.19B 21.50%
2006-03-31 $3.40B $14.44B 23.64%
2005-12-31 $3.37B $14.42B 23.56%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $136.952B $30.578B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $121.227B 17.72
Stryker (SYK) United States $72.547B 26.60
Boston Scientific (BSX) United States $51.696B 25.20
Baxter (BAX) United States $39.588B 25.33
Zimmer Biomet Holdings (ZBH) United States $25.898B 16.58
Smith & Nephew SNATS (SNN) United Kingdom $17.446B 0.00
Canopy Growth (CGC) Canada $14.852B 0.00
ResMed (RMD) United States $14.350B 27.21
Bio-Rad Laboratories (BIO) United States $9.156B 52.24
Aurora Cannabis (ACB) Canada $9.141B 64.50
Hill-Rom Holdings (HRC) United States $6.962B 21.53
Perrigo (PRGO) Ireland $6.420B 10.41
Insulet (PODD) United States $5.800B 1956.80
GW Pharmaceuticals (GWPH) United Kingdom $5.092B 0.00
ICU Medical (ICUI) United States $4.698B 29.24
Haemonetics (HAE) United States $4.311B 38.24
Hutchison China MediTech (HCM) China $3.810B 0.00
Agios Pharmaceuticals (AGIO) United States $3.637B 0.00
Neogen (NEOG) United States $3.108B 47.74
NuVasive (NUVA) United States $2.892B 25.23
Quidel (QDEL) United States $2.514B 22.68
Aphria (APHA) $2.385B 105.89
National Vision Holdings (EYE) United States $2.274B 44.72
Cardiovascular Systems (CSII) United States $1.346B 966.50
Phibro Animal Health (PAHC) United States $1.283B 18.45
VAREX IMAGING (VREX) United States $1.275B 24.96
AtriCure (ATRC) United States $1.081B 0.00
MacroGenics (MGNX) United States $0.926B 0.00
Lantheus Holdings (LNTH) United States $0.911B 24.60
Cerus (CERS) United States $0.844B 0.00
PetIQ (PETQ) United States $0.831B 23.77
Omeros (OMER) United States $0.828B 0.00
NanoString Technologies (NSTG) United States $0.729B 0.00
Meridian Bioscience (VIVO) United States $0.715B 21.30
OraSure Technologies (OSUR) United States $0.664B 29.11
Eagle Pharmaceuticals (EGRX) United States $0.657B 22.35
Evolus (EOLS) United States $0.655B 0.00
TG Therapeutics (TGTX) United States $0.601B 0.00
LeMaitre Vascular (LMAT) United States $0.596B 28.35
Surmodics (SRDX) United States $0.563B 81.90
Quanterix (QTRX) United States $0.518B 0.00
BioLife Solutions (BLFS) United States $0.364B 150.23
Vapotherm (VAPO) United States $0.335B 0.00
Rockwell Medical (RMTI) United States $0.331B 0.00
Insys Therapeutics (INSY) United States $0.328B 0.00
Utah Medical Products (UTMD) United States $0.300B 19.49
Owens & Minor (OMI) United States $0.271B 3.76
Bovie Medical (APYX) United States $0.260B 0.00
Cytosorbents (CTSO) United States $0.241B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.238B 0.00
Zynex (ZYXI) United States $0.145B 15.52
Fonar (FONR) United States $0.137B 7.33
Surface Oncology (SURF) United States $0.116B 0.00
Chimerix (CMRX) United States $0.102B 0.00
Female Health (VERU) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
United-Guardian (UG) United States $0.087B 19.84
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 17.14
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.035B 0.00
Senestech (SNES) United States $0.029B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.29